Michael Rowan
TTEE(EXO)(CEO DESIG)EVP HOS&AMB BILH at BETH ISRAEL LAHEY HEALTH PHARMACY INC · MA · Healthcare
$4.7M
Peak Total Compensation
2
Years Tracked
63x
vs. Median Household
Michael Rowan has appeared in compensation disclosures over 2 years of available data (2021–2024). Total compensation changed from $1,584,990 to $4,703,895 - a 196.8% increase.
Peak total compensation of $4,703,895 equals 63x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2024 | BETH ISRAEL LAHEY HEALTH PHARMACY INC | TTEE(EXO)(CEO DESIG)EVP HOS&AMB BILH | $2,302,117 | $2,401,778 | $4,703,895 |
| 2021 | BETH ISRAEL LAHEY HEALTH PHARMACY INC | TRUSTEE (EX-OFFICIO), CEO DESIGNATE | $1,506,636 | $78,354 | $1,584,990 |
Peers at BETH ISRAEL LAHEY HEALTH PHARMACY INC
| Name | Title | Peak Comp. |
|---|---|---|
| Kevin Tabb, MD | CEO (EX-OFF) (CEO, BILH) | $5.4M |
| Steven P Fischer | DIRECTOR, TREASURER | $1.7M |
| Cindy Rios | TREAS (EX-OFF) (EXEC VP & CFO, BILH) | $1.7M |
| Steven Fischer | BILH CFO, TRUSTEE, TREASURER (EX-OFFICIO) | $1.4M |
| Jamie Katz, ESQ | CLERK (EX-OFF); GENERAL COUNSEL BILH | $1.3M |
| Robert Fields, MD | CHAIR&TTEE (CHIEF CLIN OFF, BILH) | $1.3M |
| Jess Dejesus | PRES/TTEE (EX-OFF); CHIEF PHARM OFF | $910K |
| Efstathios Antoniades | TRUSTEE | $681K |
| Richard Fernandez | TRUSTEE | $670K |
| Jamie W Katz | DIRECTOR, SECRETARY; SVP BIDMC | $660K |
Email Alerts
Get notified about Michael Rowan
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →